Thyroid cancer exosomal SPP1 drives macrophage M2 polarization and tumor progression
Thyroid cancer-derived exosomal SPP1 promotes macrophage M2 polarization, contributing to tumor progression.
Published: July 7, 2026
Updated: July 7, 2026
Author: Humanexa Intelligence
Therapeutic area: Oncology / Thyroid Cancer
Asset: Thyroid
Indication: thyroid cancer therapies
Trial SummaryCLN
Phase III
thyroid cancer therapies
Status
Active
Signal Score
8.2
Signal assessment
Signal strength
high
Confidence level
moderate
Signalhigh
Confidencemoderate
Why it matters
The identification of SPP1's role in promoting macrophage M2 polarization in thyroid cancer presents a potential target for novel therapeutic strategies. This could reshape treatment paradigms and improve patient outcomes in oncology.
Recommended action
Humanexa recommends Monitor.
Analysis
Monitor developments in therapies targeting SPP1 and macrophage polarization in thyroid cancer.
Related companies & assets
Sources & Humanexa intelligence
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.